dc.contributor.author |
Lauschke, Volker M. |
|
dc.date.accessioned |
2025-01-13T15:24:27Z |
|
dc.date.available |
2025-01-13T15:24:27Z |
|
dc.date.issued |
2024 |
|
dc.identifier.issn |
0090-9556 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/160053 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Bethesda : Amer Soc Pharmacology Experimental Therapeutics |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1124/dmd.123.001302 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Individualized Pharmacotherapy Utilizing Genetic Biomarkers and Novel In Vitro Systems As Predictive Tools for Optimal Drug Development and Treatment |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20241001000000_01291 |
|
utue.publikation.seiten |
467-475 |
de_DE |
utue.personen.roh |
Ingelman-Sundberg, Magnus |
|
utue.personen.roh |
Lauschke, Volker M. |
|
dcterms.isPartOf.ZSTitelID |
Drug Metabolism and Disposition |
de_DE |
dcterms.isPartOf.ZS-Issue |
6 |
de_DE |
dcterms.isPartOf.ZS-Volume |
52 |
de_DE |